Traws Pharma, Inc. share price logo

Traws Pharma, Inc. Share Price

NASDAQ: TRAW

Small Cap

$2.20

+0.07

(+3.29%)

Live

as on

Traws Pharma, Inc. Stock Performance

as on November 19, 2025 at 8:44 pm IST

  • Day's Low

    Day's High

    $2.12
    $2.27
    downward going graph

    3.64%

    Downside

    3.18%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.97
    $19.44
    downward going graph

    55.91%

    Downside

    783.64%

    Upside

    downward going graph

Traws Pharma, Inc. share price movements today

Previous Close
$2.13
Open
$2.12
Volume
43.2K
Day's Low - High
$2.12 - $2.27
52 Week Low - High
$0.97 - $19.44

Traws Pharma, Inc. Historical Returns

1 Month Return
-25.52 %
3 Month Return
+ 58.96 %
1 Year Return
-54.68 %
3 Year Return
0 %
5 Year Return
0 %

Traws Pharma, Inc. Stock Fundamentals & Key Indicators

Check Traws Pharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.8M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.5

Industry PE ratio

0

PEG Ratio

0

EBITDA

-15.8M

Revenue (TTM)

2.8M

Profit Margin

0.00%

Return On Equity TTM

-1059.63%

Traws Pharma, Inc. Stock Valuation

Track how Traws Pharma, Inc. P/E has moved over time to understand its valuation trends.

Traws Pharma, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-2.89x)

June 30, 2024

Industry (0.00x)

November 19, 2025

Today (0.50x)

November 19, 2025

Highest (0.44x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.50x

Traws Pharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Traws Pharma, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Traws Pharma, Inc. image
Traws Pharma, Inc.
BUY$14.8MNA0.50.00%
Insmed Incorporated image
Insmed Incorporated
BUY$43.0B407.48%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.8B273.39%1439.191.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.3B105.46%30.5931.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$74.6B40.92%16.8932.13%

Stock Returns calculator for Traws Pharma, Inc. Stock including INR - Dollar returns

The Traws Pharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Traws Pharma, Inc. investment value today

Current value as on today

₹51,884

Returns

₹48,116

(-48.12%)

Returns from Traws Pharma, Inc. Stock

₹53,191 (-53.19%)

Dollar Returns*

₹5,076 (+5.08%)

Analyst Recommendation on Traws Pharma, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Traws Pharma, Inc.. Average target price of $6.5

Traws Pharma, Inc. Share Price Target

Get share price movements and forecasts by analysts on Traws Pharma, Inc..

What analysts predicted

66.15%UPSIDE

Target Price

$6.5

Current Price

$2.2

Analyzed by

8 Analysts

Target

$6.50

Traws Pharma, Inc. target price $6.5, a slight upside of 66.15% compared to current price of $2.2. According to 8 analysts rating.

Traws Pharma, Inc. Stock’s Investor Sentiment and Interest

Search interest for Traws Pharma, Inc. Stock has increased by 107% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:107% versus previous 30 day period

Traws Pharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
0
0
0
0
2
Gross Profit
0
0
0
0
0
0
0
0
2
Operating Income
-4
-5
-4
-5
-123
-8
-29
-5
-1
EBITDA
-4
-5
-4
-5
-123
-8
-29
21
-1
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-4
-4
-4
-123
-8
-29
21
0
Income Tax Expense
0
0
0
0
-
-
-
-
-
Net Income
-4
-4
-4
-4
-123
-8
81
15
0
Net Profit Margin
-7456.14%
-8314.04%
-7471.43%
-8898.21%
-216040.35%
-14868.42%
146298.21%
26461.40%
-33.48%

Traws Pharma, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
11
5
0
1
2
0
0
0
0
0
Gross Profit
11
5
0
1
2
0
0
0
0
0
Operating Income
-23
-23
-25
-23
-21
-24
-16
-19
-20
-49
EBITDA
-23
-19
-23
-20
-21
-24
-16
-19
-20
-166
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
0
0
0
0
0
Income Before Tax
-24
-19
-24
-20
-21
-25
-16
-18
-18
-166
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-23
-19
-24
-20
-21
-25
-16
-18
-18
-54
Net Profit Margin
-209.31%
-354.62%
-3061.25%
-1675.33%
-985.02%
-10890.48%
-7151.77%
-8391.15%
-8384.07%
-24192.04%

Traws Pharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-4
-4
-4
-123
-8
-29
21
0
-3
Operating Cash Flow
-4
-4
-4
-9
-11
-4
-5
-5
-
Investing Cash Flow
0
-
-
-3
-
-
-
-
-
Financing Cash Flow
-
-
-
13
-
19
0
3
-
Change in Cash
-4
-4
-4
0
-11
15
-5
-2
-6

Traws Pharma, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-19
-24
-20
-21
-25
-16
-18
-18
-166
Operating Cash Flow
-15
-23
-22
-20
-23
-19
-16
-17
-29
Investing Cash Flow
-
-
-
0
0
-
-
0
-3
Financing Cash Flow
17
6
35
26
19
55
-
-
33
Change in Cash
1
-17
12
5
-3
36
-16
-17
0

Traws Pharma, Inc. News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 06:03 PM

    -

    Traws Pharma reports Q3 2025 results, highlighting revenue growth and advancements in clinical programs for respiratory viral diseases.

Insights on Traws Pharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 56.0K → 2.73M (in $), with an average increase of 49.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TRAW stock has moved up by 59.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 173.5% return, outperforming this stock by 228.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 81.92M → -3.03M (in $), with an average decrease of 139.8% per quarter

About Traws Pharma, Inc.

onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. onconova has three product candidates in clinical trials and six active pre-clinical programs. onconova seeks to develop products that improve the outcome for cancer patients by directly addressing the disease, its recurrence, and the burden of side-effects associated with current methods of treatment.
OrganisationTraws Pharma, Inc.
Headquarters12 Penns Trail, Newtown, PA, United States, 18940
CEODr. Iain D. Dukes DPHIL, M.A., Ph.D.
E-voting on sharesClick here to vote

Key Management of Traws Pharma, Inc.

Name

Title

Dr. Iain D. Dukes DPHIL, M.A., Ph.D.

CEO, Secretary & Director

Mr. Charles Parker

Chief Financial Officer

Dr. Nikolay Savchuk Ph.D.

COO & Director

Dr. Robert R. Redfield M.D.

Chief Medical Officer

Dr. Charles David Pauza Ph.D.

Chief Scientific Officer of Virology

Dr. Victor Moyo M.D.

Chief Medical Officer of Oncology

FAQs

What is Traws Pharma, Inc. share price today?

Traws Pharma, Inc. share price today is $2.2 as on . Traws Pharma, Inc. share today touched a day high of $2.27 and a low of $2.12.

What is the 52 week high and 52 week low for Traws Pharma, Inc. share?

Traws Pharma, Inc. share touched a 52 week high of $19.44 on and a 52 week low of $0.97 on . Traws Pharma, Inc. stock price today i.e. is trending at $2.2,which is 88.68% down from its 52 week high and 126.80% up from its 52 week low.

What is Traws Pharma, Inc.'s market capitalisation today?

Traws Pharma, Inc. market capitalisation is $0.00T as on .

How to invest in Traws Pharma, Inc. Stock (TRAW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Traws Pharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Traws Pharma, Inc. Shares that will get you 0.6818 shares as per Traws Pharma, Inc. share price of $2.2 per share as on November 19, 2025 at 8:44 pm IST.

What is the minimum amount required to buy Traws Pharma, Inc. Stock (TRAW) from India?

Indian investors can start investing in Traws Pharma, Inc. (TRAW) shares with as little as ₹88.6 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.00 in Traws Pharma, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Traws Pharma, Inc. share’s latest price of $2.2 as on November 19, 2025 at 8:44 pm IST, you will get 4.5455 shares of Traws Pharma, Inc.. Learn more about fractional shares .